Mesenchymal Stem Cells Are The Drugstore Within

Previously, researchers have engaged mesenchymal stem cells (MSC) in preclinical animal models of disease and injury and in clinical trials during the last decade. By injecting MSCs into damaged tissue or infusing them into the blood stream, the therapy appears to have muted damage or cured such diverse conditions and disorders as acute heart attack, stroke, kidney failure, tendonitis, juvenile diabetes, radiation syndrome, arthritis, amyotrophic lateral syndrome, burns, wounds and more.  Arnold I. Caplan, from Case Western Reserve University (Ohio, USA), and colleagues have found that MSCs have the capacity to morph into a number of different tissues and thereby serve as a natural protector, healer and antibiotic maker. The team suggests that the MSC “is a drugstore that functions at the local site of injury to provide all the medicine that site requires for its successful regeneration.”